These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 22297638)
41. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis. Larsen TE; Grude TH Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):523-30. PubMed ID: 716913 [TBL] [Abstract][Full Text] [Related]
42. Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia. Sathyamoorthy H; Mahmood H; Zubir AZA; Hankinson P; Khurram SA Virchows Arch; 2024 Jan; 484(1):47-59. PubMed ID: 37882821 [TBL] [Abstract][Full Text] [Related]
43. Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma. Bedekovics J; Irsai G; Hegyi K; Beke L; Krenács L; Gergely L; Méhes G Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):579-585. PubMed ID: 27997502 [TBL] [Abstract][Full Text] [Related]
44. Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma. Henderson SA; Tetzlaff MT; Pattanaprichakul P; Fox P; Torres-Cabala CA; Bassett RL; Prieto VG; Richards HW; Curry JL J Cutan Pathol; 2014 Nov; 41(11):846-52. PubMed ID: 25263506 [TBL] [Abstract][Full Text] [Related]
45. Comparison of Proliferation Markers Ki67 and Phosphohistone-H3 (pHH3) in Breast Ductal Carcinoma In Situ. Bosch DE; Kilgore MR; Schmidt RA; Swanson PE; Rendi MH; Chang OH Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):543-547. PubMed ID: 28885232 [TBL] [Abstract][Full Text] [Related]
46. Analysis of tumor mitotic rate in thin metastatic melanomas compared with thin melanomas without metastasis using both the hematoxylin and eosin and anti-phosphohistone 3 IHC stain. Thareja S; Zager JS; Sadhwani D; Thareja S; Chen R; Marzban S; Jukic DM; Glass LF; Messina J Am J Dermatopathol; 2014 Jan; 36(1):64-7. PubMed ID: 24451214 [TBL] [Abstract][Full Text] [Related]
47. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors. Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716 [TBL] [Abstract][Full Text] [Related]
48. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507 [TBL] [Abstract][Full Text] [Related]
49. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. Thies A; Moll I; Berger J; Wagener C; Brümmer J; Schulze HJ; Brunner G; Schumacher U J Clin Oncol; 2002 May; 20(10):2530-6. PubMed ID: 12011132 [TBL] [Abstract][Full Text] [Related]
50. Mitosis count and number of cancer cells in cases of primary pulmonary adenocarcinoma: Correlations among phosphorylated histone 3, number of cancer cells, nuclear grade, pathologic features and prognosis. Inoue T; Nakazato Y; Karube Y; Maeda S; Kobayashi S; Chida M Pathol Int; 2018 Mar; 68(3):159-166. PubMed ID: 29393583 [TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. Thompson JF; Soong SJ; Balch CM; Gershenwald JE; Ding S; Coit DG; Flaherty KT; Gimotty PA; Johnson T; Johnson MM; Leong SP; Ross MI; Byrd DR; Cascinelli N; Cochran AJ; Eggermont AM; McMasters KM; Mihm MC; Morton DL; Sondak VK J Clin Oncol; 2011 Jun; 29(16):2199-205. PubMed ID: 21519009 [TBL] [Abstract][Full Text] [Related]
52. High phosphohistone H3 expression correlates with adverse clinical, biological, and pathological factors in neuroblastomas. Ramani P; Taylor S; Miller E; Sowa-Avugrah E; May MT J Histochem Cytochem; 2015 Jun; 63(6):397-407. PubMed ID: 25711230 [TBL] [Abstract][Full Text] [Related]
53. The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens. Draganova-Tacheva R; Bibbo M; Birbe R; Daskalakis C; Solomides C Acta Cytol; 2013; 57(3):291-5. PubMed ID: 23635399 [TBL] [Abstract][Full Text] [Related]
54. Prognostic utility of atypical mitoses in patients with breast cancer: A comparative study with Ki67 and phosphohistone H3. Ohashi R; Namimatsu S; Sakatani T; Naito Z; Takei H; Shimizu A J Surg Oncol; 2018 Sep; 118(3):557-567. PubMed ID: 30098295 [TBL] [Abstract][Full Text] [Related]
55. Nestin expression is associated with aggressive cutaneous melanoma of the nodular type. Ladstein RG; Bachmann IM; Straume O; Akslen LA Mod Pathol; 2014 Mar; 27(3):396-401. PubMed ID: 24030749 [TBL] [Abstract][Full Text] [Related]
56. Mitotic rate as an important prognostic factor in cutaneous malignant melanoma. Piñero-Madrona A; Ruiz-Merino G; Cerezuela Fuentes P; Martínez-Barba E; Rodríguez-López JN; Cabezas-Herrera J Clin Transl Oncol; 2019 Oct; 21(10):1348-1356. PubMed ID: 30783917 [TBL] [Abstract][Full Text] [Related]
57. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma. Barnhill RL; Katzen J; Spatz A; Fine J; Berwick M J Cutan Pathol; 2005 Apr; 32(4):268-73. PubMed ID: 15769275 [TBL] [Abstract][Full Text] [Related]
58. Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa. Gunia S; Kakies C; Erbersdobler A; Koch S; May M J Clin Pathol; 2012 Aug; 65(8):715-20. PubMed ID: 22554964 [TBL] [Abstract][Full Text] [Related]
59. Clinical, histological and quantitative prognostic factors in cutaneous malignant melanoma. Karjalainen J; Eskelinen M; Kosma VM; Lipponen P; Tuominen L; Alhava E Anticancer Res; 1992; 12(5):1507-11. PubMed ID: 1444213 [TBL] [Abstract][Full Text] [Related]
60. Mitotic Activity in Gastrointestinal Stromal Tumors: Can we use Phosphohistone H3 Immunohistochemistry Instead of Hematoxylin and Eosin for Mitotic Count? Erhan SS; Sensu S; Keser SH; Kangal E; Gul AE; Gundogan GA; Sakin A Sisli Etfal Hastan Tip Bul; 2022; 56(2):276-283. PubMed ID: 35990307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]